Expert network works towards better drug development for children

IMI project conect4children has pioneered an advice process involving diverse experts including patients to aid drug developers when designing paediatric clinical trials.

Biomarkers, not biopsies, indicate who will fall foul of liver disease

LITMUS is studying how simple blood tests or scans could replace surgical biopsies as a means to identify people with the liver disease non-alcoholic staetohepatitis (NASH).

Drug developers hunt for clues to organ stress

IMI project TransBioLine is identifying new markers that flag up when a medicine may be harmful to vital organs such as the liver or kidneys, for example.

Psoriasis project benefits from patient research partners’ perspective

IMI psoriasis project HIPPOCRATES is a great example of best practice when it comes to patient involvement in research, and it’s already seeing the benefits of its approach.

IHI call 3 – deadline approaching

The deadline for IHI call 3 is 15 March! If you have any questions about the call, don’t hesitate to contact the IHI Programme Office.

Sign up for our webinar on health and the blockchain

IMI project PharmaLedger set out to apply blockchain technology to the healthcare sector. A webinar on 28 February will showcase the project’s results and use cases.

IMI projects showcase results at DIA Europe

IMI projects are presenting results on remote clinical trials, patient information, health data, and real world evidence at the upcoming event.

Sign up for the Mobilise-D summer school

The one-week course will be held in Italy and will focus on ‘digital mobility outcomes for health promotion and prevention: extracting actionable insights from real-world data’.